Watch Ticker

Heron Therapeutics, Inc.

Go to Heron Therapeutics, Inc. Website

$1.81

0.06 (3.43%)
Live
Previous Close

$1.75

Day Range

$1.725 - $1.83

Previous Day Range

$1.68 - $1.76

Market Cap

$257.8 million USD

Day Vol.

894071

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, Z...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Heron Therapeutics, a commercial-stage biotechnology company, will host a conference call on November 12, 2024, to report its third quarter 2024 financial results and discuss recent business highlights.

Related tickers: HRTX.

Read Full Article

The global chemotherapy-induced nausea and vomiting treatment market is expected to grow at a CAGR of 6.4% and reach a valuation of US$ 12,688.0 million by 2034, driven by the increasing incidence of cancer and the need for effective management of CINV.

Related tickers: PFE, GSK, ABBV, MRK, BHC, NVS, HRTX.

Read Full Article
Trending Tickers

Please sign in to view